T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis (Q28084998)

Thomas J Lowery

series ordinal

3

1 reference

language of work or name

1 reference

2016

1 reference

1 reference

11

1 reference

PubMed

issue

1

1 reference

PubMed

page(s)

103-17

1 reference

Hidden killers: human fungal infections

PubMed

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Epidemiology of invasive mycoses in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Effect of antifungal therapy timing on mortality in cancer patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

The case for antifungal stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood--proof of concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Molecular and nonmolecular diagnostic methods for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Novel nanosensors for rapid analysis of telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

National surveillance of fungemia in Denmark (2004 to 2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Quantitation of Candida CFU in initial positive blood cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Multistate point-prevalence survey of health care-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis - a systemic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Enhancing molecular approaches for diagnosis of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Comparison of BD Bactec Plus Aerobic/F medium to VersaTREK Redox 1 blood culture medium for detection of Candida spp. in seeded blood culture specimens containing therapeutic levels of antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Blood cultures: key elements for best practices and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Towards a targeted, risk-based, antifungal strategy in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Excess mortality, length of stay and cost attributable to candidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

The economic impact of rapid Candida species identification by T2Candida among high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Better tests, better care: improved diagnostics for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.111

21 January 2018

Identifiers

DOI

10.2217/FMB.15.111

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

26371384

1 reference

Consolidated OpenCitations Corpus – April 2017